Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000591943.6
CAP
Last updated in GTR:
2024-08-30
View version history
GTR000591943.6,
last updated:
2024-08-30
GTR000591943.5,
last updated:
2023-08-28
GTR000591943.4,
last updated:
2022-08-30
GTR000591943.3,
last updated:
2021-01-24
GTR000591943.2,
last updated:
2020-11-16
GTR000591943.1,
registered in GTR:
2020-11-12
Last annual review date for the lab: 2024-08-30
LinkOut
At a Glance
Test purpose:
Help
Diagnosis
Conditions (110):
Help
Adult hypophosphatasia;
ACTH-independent macronodular adrenal hyperplasia 1;
Aicardi-Goutieres syndrome 7
more...
Genes (50):
Help
Methods (1):
Help
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Individuals with a phenotype consistent with inherited low bone density
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
BZM
Specimen Source:
Help
- Cell culture
- Cord blood
- Fibroblasts
- Isolated DNA
- Peripheral (whole) blood
- Saliva
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
Test Order Code:
Help
LowBoneDensityZoom
View other test codes
View other test codes
CPT codes:
Help
Lab contact:
Help
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Submit sample with completed requisition form.
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 110
| Condition/Phenotype | Identifier |
|---|
Test Targets
Genes
Help
Total genes: 50
| Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
|---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Target population:
Help
Individuals with a phenotype consistent with inherited low bone density
View citations (1)
- none
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
Variants are classified using the Standards and guidelines for the interpretation of sequence variants published by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (Richards et al, 2015, PMID 25741868).
Variants are classified using the Standards and guidelines for the interpretation of sequence variants published by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (Richards et al, 2015, PMID 25741868).
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
Yes. Our VUS resolution program involves targeting additional family members for a VUS, with the intention of this additional information aiding in reclassification of the variant. In order to qualify for our VUS resolution program, your patient must have at least one VUS listed on a test report that was issued … View more
Yes. Our VUS resolution program involves targeting additional family members for a VUS, with the intention of this additional information aiding in reclassification of the variant. In order to qualify for our VUS resolution program, your patient must have at least one VUS listed on a test report that was issued … View more
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Not provided.
Not provided.
Recommended fields not provided:
Clinical validity,
Clinical utility,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Sequencing: >94% for single nucleotide and >76% for small insertion/deletion variants for the nucleotides evaluated. Exonic deletions/duplications: >97% for unique regions of the genome. This test is not validated to identify small deletions/insertions of greater than 20bp, exonic deletions and duplications in pseudogenes or other repetitive regions of the genome …
View more
View citations (1)
- none
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.